Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CNS
|
Edmond D Villani
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 1.77% |
-
|
Oct 02
2017 |
|
CNS
|
Martin Cohen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 0.01% |
-
|
Oct 02
2017 |
|
CNS
|
Reena Aggarwal
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 21.11% |
-
|
Oct 02
2017 |
|
CNS
|
Richard P Simon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 1.73% |
-
|
Oct 02
2017 |
|
CNS
|
Peter L Rhein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 633 Added 2.0% |
-
|
Oct 02
2017 |
|
CLDR
|
Accel X LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,069,792 Reduced 59.63% |
$32,682,016
$15.79 p/Share
|
Oct 02
2017 |
|
CLDR
|
Accel X LP
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 4,459,070 Reduced 35.41% |
$70,408,715
$15.79 p/Share
|
Oct 02
2017 |
|
AXP
|
James Peter Bush
Senior Advisor to the CEO |
SELL
Open market or private sale
|
Direct | 10,230 Reduced 11.46% |
$926,122
$90.53 p/Share
|
Oct 02
2017 |
|
AXP
|
James Peter Bush
Senior Advisor to the CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 12,000 Added 11.85% |
$418,080
$34.84 p/Share
|
Oct 02
2017 |
|
NVDA
|
Michael Byron
Principal Accounting Officer |
SELL
Open market or private sale
|
Direct | 9,538 Reduced 7.68% |
$1,714,932
$179.8 p/Share
|
Oct 02
2017 |
|
PEN
|
Thomas Wilder
Director |
SELL
Open market or private sale
|
Indirect | 345 Reduced 11.12% |
$31,119
$90.2 p/Share
|
Oct 02
2017 |
|
TSLA
|
Kimbal Musk
Director |
SELL
Open market or private sale
|
Direct | 2,190 Reduced 1.39% |
$748,564
$341.81 p/Share
|
Oct 02
2017 |
|
PRTA
|
Dennis J. Selkoe |
SELL
Open market or private sale
|
Direct | 3,500 Reduced 55.16% |
$225,575
$64.45 p/Share
|
Oct 02
2017 |
|
PRTA
|
Dennis J. Selkoe |
BUY
Exercise of conversion of derivative security
|
Direct | 3,500 Added 35.55% |
$57,470
$16.42 p/Share
|
Oct 02
2017 |
|
EVBG
|
Elliot J. Mark
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 2,500 Reduced 64.09% |
$67,025
$26.81 p/Share
|
Oct 02
2017 |
|
EA
|
Chris Bruzzo
Chief Experience Officer |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 3.49% |
$177,330
$118.22 p/Share
|
Oct 02
2017 |
|
EA
|
Laura Miele
President of EA Entertainment |
SELL
Open market or private sale
|
Direct | 750 Reduced 11.1% |
$88,785
$118.38 p/Share
|
Oct 02
2017 |
|
EA
|
Patrick Soderlund
Chief Design Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 9.32% |
$944,960
$118.12 p/Share
|
Oct 02
2017 |
|
EA
|
Andrew Wilson
Chairman & CEO |
SELL
Open market or private sale
|
Indirect | 10,058 Reduced 10.06% |
$1,188,856
$118.2 p/Share
|
Oct 02
2017 |
|
SQ
|
Roelof Botha
Director |
BUY
Grant, award, or other acquisition
|
Direct | 477 Added 1.06% |
-
|
Oct 02
2017 |
|
SQ
|
James Morgan Mc Kelvey Jr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 347 Added 0.32% |
-
|
Oct 02
2017 |
|
SQ
|
David A Viniar
Director |
BUY
Grant, award, or other acquisition
|
Direct | 542 Added 0.96% |
-
|
Oct 02
2017 |
|
SQ
|
Mary G Meeker
Director |
BUY
Grant, award, or other acquisition
|
Direct | 477 Added 0.23% |
-
|
Oct 02
2017 |
|
RAD
|
Kermit R Crawford
President and COO |
BUY
Grant, award, or other acquisition
|
Direct | 975,610 Added 50.0% |
-
|
Oct 02
2017 |
|
TG
|
Gamco Investors, Inc. Et Al |
SELL
Open market or private sale
|
Indirect | 1,500 Reduced 100.0% |
$27,375
$18.25 p/Share
|
Oct 02
2017 |
|
WEN
|
Peltz Nelson |
BUY
Grant, award, or other acquisition
|
Direct | 1,117 Added 0.01% |
$16,867
$15.1 p/Share
|
Oct 02
2017 |
|
MTB
|
Brent D Baird
Director |
BUY
Grant, award, or other acquisition
|
Direct | 259 Added 0.82% |
$41,709
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
C Angela Bontempo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 109 Added 0.87% |
$17,553
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Robert T Brady
Director |
BUY
Grant, award, or other acquisition
|
Direct | 93 Added 1.08% |
$14,977
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
T Jefferson Cunningham Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 126 Added 1.08% |
$20,291
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Gary N Geisel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 130 Added 0.69% |
$20,935
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Richard A. Grossi
Director |
BUY
Grant, award, or other acquisition
|
Direct | 102 Added 5.59% |
$16,426
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
John D. Hawke Jr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 128 Added 2.22% |
$20,613
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Richard H. Ledgett Jr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 62 Added 50.0% |
$9,984
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Melinda R Rich
Director |
BUY
Grant, award, or other acquisition
|
Direct | 84 Added 0.6% |
$13,527
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Newton P S Merrill
Director |
BUY
Grant, award, or other acquisition
|
Direct | 93 Added 7.62% |
$14,977
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Robert E Sadler Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 129 Added 0.24% |
$20,774
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Denis J Salamone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 101 Added 0.11% |
$16,265
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
Herbert L Washington
Director |
BUY
Grant, award, or other acquisition
|
Direct | 101 Added 0.89% |
$16,265
$161.04 p/Share
|
Oct 02
2017 |
|
MTB
|
David S Scharfstein
Director |
BUY
Grant, award, or other acquisition
|
Direct | 92 Added 32.28% |
$14,816
$161.04 p/Share
|
Oct 02
2017 |
|
CVS
|
Thomas M Moriarty
EVP & General Counsel |
SELL
Open market or private sale
|
Direct | 20,547 Reduced 47.59% |
$1,667,800
$81.17 p/Share
|
Oct 02
2017 |
|
CVS
|
Thomas M Moriarty
EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 20,547 Added 32.24% |
-
|
Oct 02
2017 |
|
INTC
|
Brian M Krzanich
CEO |
SELL
Open market or private sale
|
Direct | 61,860 Reduced 11.37% |
$2,396,457
$38.74 p/Share
|
Oct 02
2017 |
|
INTC
|
Brian M Krzanich
CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 33,860 Added 5.86% |
$907,448
$26.8 p/Share
|
Oct 02
2017 |
|
ORCL
|
Dorian Daley
EVP and General Counsel |
SELL
Open market or private sale
|
Direct | 23,297 Reduced 42.92% |
$1,141,553
$49.0 p/Share
|
Oct 02
2017 |
|
ORCL
|
Dorian Daley
EVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 23,297 Added 30.03% |
$701,473
$30.11 p/Share
|
Oct 02
2017 |
|
COST
|
Richard A Galanti
Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct | 4,769 Reduced 9.44% |
$791,129
$165.89 p/Share
|
Oct 02
2017 |
|
COST
|
Richard A Galanti
Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct | 19,570 Added 27.91% |
-
|
Oct 02
2017 |
|
COST
|
W Craig Jelinek
Director |
SELL
Payment of exercise price or tax liability
|
Direct | 9,904 Reduced 3.02% |
$1,642,975
$165.89 p/Share
|
Oct 02
2017 |
|
COST
|
W Craig Jelinek
Director |
BUY
Grant, award, or other acquisition
|
Direct | 37,360 Added 10.22% |
-
|
Oct 02
2017 |